These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 39284371)

  • 1. Characterization of fission and fusion mitochondrial dynamics in HD fibroblasts according to patient's severity status.
    Gharaba S; Sprecher U; Baransi A; Muchtar N; Weil M
    Neurobiol Dis; 2024 Oct; 201():106667. PubMed ID: 39284371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant migration features in primary skin fibroblasts of Huntington's disease patients hold potential for unraveling disease progression using an image based machine learning tool.
    Gharaba S; Shalem A; Paz O; Muchtar N; Wolf L; Weil M
    Comput Biol Med; 2024 Sep; 180():108970. PubMed ID: 39096606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of overexpression of huntingtin proteins on mitochondrial integrity.
    Wang H; Lim PJ; Karbowski M; Monteiro MJ
    Hum Mol Genet; 2009 Feb; 18(4):737-52. PubMed ID: 19039036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased mitochondrial fission and neuronal dysfunction in Huntington's disease: implications for molecular inhibitors of excessive mitochondrial fission.
    Reddy PH
    Drug Discov Today; 2014 Jul; 19(7):951-5. PubMed ID: 24681059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial cristae remodelling is associated with disrupted OPA1 oligomerisation in the Huntington's disease R6/2 fragment model.
    Hering T; Kojer K; Birth N; Hallitsch J; Taanman JW; Orth M
    Exp Neurol; 2017 Feb; 288():167-175. PubMed ID: 27889468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.
    Shirendeb U; Reddy AP; Manczak M; Calkins MJ; Mao P; Tagle DA; Reddy PH
    Hum Mol Genet; 2011 Apr; 20(7):1438-55. PubMed ID: 21257639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
    Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.
    Kim J; Moody JP; Edgerly CK; Bordiuk OL; Cormier K; Smith K; Beal MF; Ferrante RJ
    Hum Mol Genet; 2010 Oct; 19(20):3919-35. PubMed ID: 20660112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial alterations accompanied by oxidative stress conditions in skin fibroblasts of Huntington's disease patients.
    Jędrak P; Mozolewski P; Węgrzyn G; Więckowski MR
    Metab Brain Dis; 2018 Dec; 33(6):2005-2017. PubMed ID: 30120672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.
    Joshi AU; Ebert AE; Haileselassie B; Mochly-Rosen D
    J Mol Cell Cardiol; 2019 Feb; 127():125-133. PubMed ID: 30550751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin.
    Jin YN; Yu YV; Gundemir S; Jo C; Cui M; Tieu K; Johnson GV
    PLoS One; 2013; 8(3):e57932. PubMed ID: 23469253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
    Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
    Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CRMP2 in Regulation of Mitochondrial Morphology and Motility in Huntington's Disease.
    Brustovetsky T; Khanna R; Brustovetsky N
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli.
    Costa V; Giacomello M; Hudec R; Lopreiato R; Ermak G; Lim D; Malorni W; Davies KJ; Carafoli E; Scorrano L
    EMBO Mol Med; 2010 Dec; 2(12):490-503. PubMed ID: 21069748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial organization and structure are compromised in fibroblasts from patients with Huntington's disease.
    Vanisova M; Stufkova H; Kohoutova M; Rakosnikova T; Krizova J; Klempir J; Rysankova I; Roth J; Zeman J; Hansikova H
    Ultrastruct Pathol; 2022 Sep; 46(5):462-475. PubMed ID: 35946926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.
    Guo X; Disatnik MH; Monbureau M; Shamloo M; Mochly-Rosen D; Qi X
    J Clin Invest; 2013 Dec; 123(12):5371-88. PubMed ID: 24231356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease affects mitochondrial network dynamics predisposing to pathogenic mitochondrial DNA mutations.
    Neueder A; Kojer K; Gu Z; Wang Y; Hering T; Tabrizi S; Taanman JW; Orth M
    Brain; 2024 Jun; 147(6):2009-2022. PubMed ID: 38195181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.
    Gan X; Huang S; Wu L; Wang Y; Hu G; Li G; Zhang H; Yu H; Swerdlow RH; Chen JX; Yan SS
    Biochim Biophys Acta; 2014 Feb; 1842(2):220-31. PubMed ID: 24252614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
    Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
    Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.